Replies to post #502062 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

That's exactly the hope...

hopefully the system is sophisticated enough to distinguish between rational precision medicine and random alignment.

and is what could get us an approval recommendation from the CHMP.

As is know here - imo., thus a Conditional Marketing Authorisation (CMA) with a controlled confirmatory trial to verify that the subgroup efficacy, survival bias, consolidated 30mg cohort etc. isn't just showing a random result.